@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com 3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com 3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com 4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com 4 years ago
Acutus, Maker of Next-Gen Electrophysiology Tech, Adds $100M Series D
@xconomy.com 5 years ago
Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise
@xconomy.com 5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com 5 years ago
Providence Ventures Raises $150M to Invest in Healthtech Startups
@xconomy.com 5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com 5 years ago
Madison Startup Asto CT Raises $1.1M for Large Animal Imaging Device
@xconomy.com 5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com 5 years ago
The Biggest Wisconsin Venture Round of the Decade… Didn’t Happen
@xconomy.com 5 years ago
Austin’s Ambiq Micro Adds $11M for Energy-Efficient Microcontrollers
@xconomy.com 5 years ago
Strangeworks, TMCx, SeriesX, Unchained Capital, ALTR, & More TX Tech
@xconomy.com 6 years ago
OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million
@xconomy.com 6 years ago
Fictiv Raises $15M To Connect Tech Innovators & Parts Manufacturers